Apr 14, 2009 - SpePharm Holding BV announces it intends to file a claim for financial damages and losses of not less than Thirty Five Million Euros against BioAlliance Pharma SA, a French company listed on Paris Euronext.
The details can be read here.
No comments:
Post a Comment